TickerFacts.

Charlie's Holdings, Inc. (CHUC): Cost of Revenue

Annual figures by period end, from SEC filings.

$15.26M
Year ended 2025-12-31
$19.10M
Trailing 12 months to 2026-06-30
+15.3%
5-year compound annual growth
2018-12-31: $8.52M2019-12-31: $10.07M2020-12-31: $7.48M2024-12-31: $4.89M2025-12-31: $15.26M$15.26M
2018-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$15.26M+212.2%2026-04-01, From 2025-01-01
2024-12-31$4.89Mn/a2026-04-01, From 2024-01-01
No annual figure between 2020-12-31 and 2024-12-31.
2020-12-31$7.48M-25.7%2021-04-05, From 2020-01-01
2019-12-31$10.07M+18.3%2021-04-05, From 2019-01-01
2018-12-31$8.52Mn/a2020-04-14, From 2018-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Charlie's Holdings, Inc. (CHUC)2025-12-31$15.26M+212.2%
Bon Natural Life Ltd (BON)2025-09-30$14.79M-11.6%
Cyanotech Corp (CYAN)2025-03-31$17.34M+1.2%
Synergy CHC Corp. (SNYRQ)2025-12-31$10.08M-9.9%
C21 Investments Inc. (CWLXF)2026-03-31$19.01M+8.3%
Leef Brands Inc. (LEEEF)2025-12-31$24.30M+16.8%
Functional Brands Inc. (MEHA)2025-12-31$3.13M+5.7%
Fitlife Brands, Inc. (FTLF)2025-12-31$50.01M+37.4%
Healthy Extracts Inc. (HYEX)2025-12-31$2.09M+73.8%

Compare CHUC, BON, CYAN, SNYRQ side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗